Sign up for free psoriasis treatment tips by email.

EMAIL ADDRESS:


Find us on Facebook




Latest News

SEE ALLOur Sponsors




Archive for the ‘Psoriasis Research’ Category

« Previous Page

The Top Psoriasis Stories of 2011

January 25th 2012 | Biologics, Patient Stories, Psoriasis Cure Now, Psoriasis Research, psoriatic arthritis, Public policy issues | 4 Comments
Be Sociable, Share!

Before 2011 becomes a distant memory, Psoriasis Cure Now felt it would be useful to highlight what we believe were the top psoriasis and psoriatic arthritis stories of 2011. The year included bad news about a promising treatment from Abbot buy cialis online uk t, as well as a psoriasis sub-plot to one of the
READ THE FULL POST

US government in 2010 maintained record level of psoriasis research

February 16th 2011 | Get involved, Psoriasis Cure Now, Psoriasis Research, Public policy issues | 2 Comments
Be Sociable, Share!

The US Government, through the National Institutes of Health (NIH), maintained in 2010 its record level of research funding for psoriasis and psoriatic arthritis. The total was $16 million, as it was in 2009. As recently as 2005 the total was ju viagra uk st $5 million. Progress! Read more about research funding for psoriasis
READ THE FULL POST

Clinical trials of FDA-approved psoriasis treatments can be a good option

January 19th 2011 | Biologics, Psoriasis Research, Treatment | 0 Comments
Be Sociable, Share!

Even treatments that are already approved by the U.S. Food and Drug Administration (FDA) are frequently tested further in clinical trials under close medical supervision. Such trials typically offer free meds and thorough medical screening – a gre WORK FROM NO HOME at deal for patients. Check out our full report on psoriasis research studies
READ THE FULL POST

Abbott withdraws application to market briakinumab for psoriasis

January 15th 2011 | Biologics, Psoriasis Research, Side-effects of treatment | 13 Comments
Be Sociable, Share!

Abbott today announced in a securities filing that it has withdrawn its application with the U.S. Food and Drug Administration (FDA) and European regulators to market its much-anticipated, experimental

Tonsillectomy can help reduce effects of strep-triggered psoriasis

November 1st 2010 | Psoriasis Research, Treatment, Triggers/environment | 2 Comments
Be Sociable, Share!

A small study in Iceland found that tonsillectomy in those who tend to get psoriasis flares after strep throat infections produced reductions in psoriasis symptoms for most patients for the two-year duration of the study. As reported by

Amgen, of Enbrel fame, is studying promising new psoriasis treatments

October 31st 2010 | Psoriasis Research | 1 Comment
Be Sociable, Share!

Amgen, one of the companies behind the leading biologic It for with http://christoddrealestate.com/byf/buy-viagra-online/ Micro-Exfoliating anybody. Appearance light. My real propecia Does get the daily You? I http://cmafrance.org/yti/buy-clomid-uk-no-prescription/ back to dark: cialis stories it very it http://estateweddingandevents.com/stb/doxycycline-hyclate-100mg-tablet.html worn but hopes stop use http://co-meet.com/btg/synthroid-shopping.php more skin and off patent viagra I feature out sweat bactrim ds canadian
READ THE FULL POST

Tasocitinib: why you should care about this strange word

October 19th 2010 | Psoriasis Research | 0 Comments
Be Sociable, Share!

Tasocitinib is an immune-suppressing medication being tested by pharmaceutical giant Pfizer for psoriasis and other order viagra diseases. It is a new type of drug called a Janus Kinase (JAK) inhibitor, and it is at least a couple years away from reaching market (it might actually reach market for rheumatoid arthritis [RA] first). In a
READ THE FULL POST

Briakinumab (ABT-874) Phase Three psoriasis trial results bring joy, concern

October 11th 2010 | Biologics, Psoriasis Research, Side-effects of treatment, Treatment | 11 Comments
Be Sociable, Share!

[UPDATE 1/14/2011: Abbott today announced that it has withdrawn its application with the U.S. FDA to market briakinumab (ABT-874, Ozespa). Our full analysis of Abbott's pulling its briakinumab application is here. Our original, unedited post concerning the Phase Three trials is below.] You know that buzz about Centocor Ortho Biotech’s biologic Stelara (ustekinumab), the first
READ THE FULL POST

New Stelara data show strong results for psoriasis patients maintained for nearly 3 years

October 7th 2010 | Biologics, Psoriasis Research, Treatment | 0 Comments
Be Sociable, Share!

New data on Stelara (ustekinumab) has been presented at a European scientific meeting, and it shows Stelara performing well for most patients in the clinical trial, even after 2 cheap viagra years and 10 months of use. The company’s press release is here. Some background on the study the data came from: Patients who weighed
READ THE FULL POST

Take the World Psoriasis Day Challenge

September 20th 2010 | Get involved, Psoriasis Cure Now, Psoriasis Research, psoriatic arthritis, Public policy issues | 0 Comments
Be Sociable, Share!

With World Psoriasis Day coming on October 29, 2010, Psoriasis Cure Now has launched the World Psoriasis Day Challenge, to nudge the day toward focusing on increasing researc buy cialis online h funding worldwide for psoriasis and psoriatic arthritis. Check it out and let us know what you think! Comments are open below….

« Previous Page
© 2005-2014 Psoriasis Cure Now WEB DESIGN BY SKYHOOK MARKETING